FDA Tentative Approval: REMODULIN — Supplemental Application (United Therapeutics Corporation)

View source ↗

Summary

FDA has issued tentative approval for a United Therapeutics supplemental submission for REMODULIN (treprostinil).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Remodulin (treprostinil)

Snippet

SUPPL TA for REMODULIN (TREPROSTINIL)